The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ALNY FINANCIAL STATEMENTS

Alnylam Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ALNYAlnylam Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
02 B4 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue4.8 B $Gross Profit3.8 B $ · 80%Operating Income999.8 M $ · 21%Pre-tax Income799.6 M $ · 17%Net Income to Owners808 M $ · 17%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue4.8 B $+95.1%
Gross Profit3.8 B $+86.0%
Operating Income999.8 M $—
EBITDA1.2 B $—
Net Income to Owners808 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets5.6 B
  • Equity1.4 B $24%
  • Current Liabilities1.5 B $27%
  • Long-term Liabilities2.7 B $48%

Key Figures

YoY change
Total Assets5.6 B $+21.7%
Total Liabilities4.2 B $-2.6%
Total Equity1.4 B $+440.4%
Cash & ST Investments3.3 B $+15.8%
Total Debt1.3 B $-53.7%
Net Debt-440.9 M $-127.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-500 M0500 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M400 M600 M634.5 M $Operating74.9 M $Investing-364.2 M $Financing345.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow634.5 M $—
Capital Expenditures91.9 M $+151.6%
Free Cash Flow542.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ALNY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.